NexSite HD Hemodialysis Catheter NEXHD1555501Recalls & reported problems
Marvao Medical Devices Limited · The NexSite™ HD, Hemodialysis Catheter for long term use is a dual lumen, stepped tip radiopaque polyurethane catheter which contains a Dacron biomaterial cuff and two female luer connectors. The DISC (Dermal Ingrowth Support Collar) assists with the direction of the catheter and consists of a biomaterial tissue ingrowth scaffold. The biomaterial scaffolds on the catheter shaft and DISC are aligned and facilitate tissue ingrowth, which is considered important in reducing the source of extraluminal infection in patients requiring long term catheterisation. The Catheter, DISC and the following ancillary components required for the procedure (0.038” guidewire, Stainless Steel Tunneler and Sleeve, 16Fr Introducer / Dilator, Coring Scalpel and Luer Caps) are provided in a tray, sealed with a Tyvek lid and placed in a second sterile pouch so that the tray can be delivered to the sterile field · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05391525640105), received between Nov 16, 2015 and Apr 29, 2016 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Contamination” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Appropriate Device Problem Term/Code Not Available1
- Contamination1
Patient problems
- Bacterial Infection2
- Fever1
- Inflammation1
- Pain1
- Purulent Discharge1
- Staphylococcus Aureus1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryApr 29, 2016Contamination
STUDY (B)(6): THE NEXSITE DEVICE WAS SUCCESSFULLY PLACED ON (B)(6) 2016 IN THE RIGHT FEMORAL VEIN. THIS (B)(6) OLD FEMALE HAD NO ISSUES UNTIL (B)(6) 2016 WHEN RN FOUND YELLOW EXUDATE AT CATHETER EXIT SITE WHILE CHANGING DRESSING. PATIENT HAD NO COMPLAINTS OF FEVER OR CHILLS, NO ABNORMAL VITAL SIGNS. PATIENT DENIED DRAINAGE AT EXIT SITE PREVIOUS TO RN ASSESSMENT. ACCESS RUNNING WELL. EXIT SITE CULTURE TAKEN ON (B)(6) 2016. STAPH EPIDERMIDIS POSITIVE CULTURE RESULT ON (B)(6) 2016. PATIENT STARTED ON VANCO 1000MG IV QHD PER SENSITIVITY REPORT AND SENT TO RAC FOR NEXSITE REMOVAL. PATIENT SEEN AT RAC ON (B)(6) 2016. PER RAC REPORT, PURULENT DRAINAGE NOTED AT EXIT SITE AS WELL AS ABSCESS. CATHETER REMOVED. NEW RIGHT FEMORAL CANNON CATHETER WAS PLACED. PATIENT REMAINS PC DEPENDENT AS NO OTHER OPTIONS FOR AVG/AVF OR HERO. THERE WERE NO BLOOD CULTURES DRAWN AS ASSESSMENT BENIGN WITH EXCEPTION OF EXIT SITE EXUDATE. PATIENT HAS NOT BEEN HOSPITALIZED RECENTLY, NOR HAS SHE HAD ANY POSITIVE BLOOD CULTURES. LAST CULTURE DRAWN IN CENTER (B)(6) 2015 WHICH WAS NEGATIVE FOR GROWTH.
Patient problems: Bacterial Infection; Purulent Discharge
MAUDE report 5619119 ↗MalfunctionNov 16, 2015Appropriate Device Problem Term/Code Not Available
(B)(4): THIS (B)(6) FEMALE PATIENT HAD A NEXSITE DEVICE PLACED IN THE RIGHT FEMORAL VEIN ON (B)(6) 2015. THE CATHETER WAS EXCHANGED WITH A NON-NEXSITE CATHETER OVER A WIRE AT A LOCAL HOSPITAL DUE TO "DYSFUNCTIONAL CATHETER" ON (B)(6) 2015. THERE WERE NO SPECIFICS AS TO WHETHER THEY COULDN'T ASPIRATE OR IF IT WAS AN INADEQUATE BLOOD FLOW. THERE WAS NO RECORD OF DISC REMOVAL. THE PATIENT WAS ADMITTED ON (B)(6) 2015 WITH POSITIVE BLOODS ((B)(6)), PAIN IN RIGHT LOWER EXTREMITY AND FEVERS. A CT OF THE RIGHT LOWER EXTREMITY SHOWED A CURVILINEAR FOREIGN BODY, SUSPECTED TO BE AND EVENTUALLY CONFIRMED AS RETAINED DISC FROM STUDY CATHETER IN THE RIGHT UPPER ANTERIOR THIGH. ALSO ADJACENT FLUID COLLECTION AND ADENOPATHY WITH OVERLYING SKIN INFLAMMATION. THE CATHETER WAS REMOVED AT BEDSIDE ON (B)(6) 2015. VASCULAR SURGEON DID INCISION AND DRAINAGE ON (B)(6) 2015 AND REMOVED THE DISC. THE PATIENT WAS INITIALLY PLACED ON VANCOMYCIN AND ZOSYN AND THIS WAS CHANGED TO VANCOMYCIN ONLY AND CONTINUED UNTIL (B)(6) 2015. FOLLOW UP CULTURES WERE NEGATIVE PRIOR TO DISCHARGE FROM HOSPITAL. A TUNNELLED DIALYSIS CATHETER WAS PLACED IN LEFT FEMORAL. THE CURRENT CONDITION OF THE PATIENT IS STABLE.
Patient problems: Bacterial Infection; Fever; Inflammation; Pain; Staphylococcus Aureus
MAUDE report 5225263 ↗
Other Catheter, Hemodialysis, Implanted devices
- Palindrome 8888145014Mozarc Medical US LLC · Catheter, hemodialysis, implanted1 recall312 reports
- Palindrome 8888145015Mozarc Medical US LLC · Catheter, hemodialysis, implanted2 recalls1 death219 reports
- HemoStar Long-Term Hemodialysis Catheter 5833690Bard Access Systems, Inc. · Catheter, hemodialysis, implanted2 deaths290 reports
- Palindrome 8888119369PMozarc Medical US LLC · Catheter, hemodialysis, implanted3 recalls1 death14 reports
- HemoStar Long-Term Hemodialysis Catheter 5833730Bard Access Systems, Inc. · Catheter, hemodialysis, implanted1 death141 reports
- GlidePath Long-Term Hemodialysis Catheter with Preloaded Stylet 5393230Bard Access Systems, Inc. · Catheter, hemodialysis, implanted5 deaths138 reports
- Palindrome 8888123404PMozarc Medical US LLC · Catheter, hemodialysis, implanted2 recalls1 death17 reports
- Palindrome 8888119364PMozarc Medical US LLC · Catheter, hemodialysis, implanted2 recalls1 death17 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page